We are live on ! Find out more
MHUA

Meihua International Medical Technologies

Delisted

MHUA was delisted on the 8th of December, 2025.

5 hedge funds and large institutions have $65.8K invested in Meihua International Medical Technologies in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.83% less ownership

Funds ownership: 1.35%0.52% (-0.83%)

44% less capital invested

Capital invested by funds: $118K → $65.8K (-$52.1K)

44% less funds holding

Funds holding: 95 (-4)

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

Holders
5
Holders Change
-4
Holders Change %
-44.44%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
3
Reduced
Closed
5
Calls
Puts
Net Calls
Net Calls Change

MHUA Hedge Fund Activity: Q2 2025 in Review

5 of the 7,614 institutional investors tracked by Wall St. Rank reported a position in Meihua International Medical Technologies (MHUA) for Q2 2025, worth a combined $65.8K — down 44% from $118K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of MHUA and 1 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 3 added.

The largest buyer was Two Sigma Securities, opening a new position worth an estimated $6.02K. The largest seller was Citadel Advisors, exiting entirely with an estimated $50.5K sold.

  • 5 institutional investors held Meihua International Medical Technologies (MHUA) as of Q2 2025, down from 9 in Q1 2025.
  • Funds reported $65.8K of Meihua International Medical Technologies stock for Q2 2025, down 44% quarter-over-quarter.
  • 1 fund opened new Meihua International Medical Technologies positions in Q2 2025 and 5 closed out, a net change of -4 holders.
  • The largest Meihua International Medical Technologies buyer in Q2 2025 was Two Sigma Securities, an estimated $6.02K added.
  • The largest Meihua International Medical Technologies seller in Q2 2025 was Citadel Advisors, an estimated $50.5K sold.

Based on aggregated 13F filings for Q2 2025.